What challenges do biotechs typically face?

Four main challenges include high industry competitiveness, scientific and technical uncertainty, limited funding and financial risk and building and managing the right team.

How competitive is the biotech industry?

Biotechs are racing to develop novel treatments using unproven science, facing rising development costs, crowded clinical trial markets and increasing pressure to produce meaningful data.

What risks do biotechs face in early stage development?

Early stage compounds often target areas with little existing data. A failed compound can be devastating since many emerging biotechs only have one or two assets in the pipeline. Missteps in site selection or trial execution can result in delays and financial setbacks.

How can biotechs address funding concerns?

Biotech products can take years to reach the market. This requires multiple funding rounds, each tied to development milestones. Biotechs need to meet their milestones to build investor trust and secure future funding.

How important is biotech project management?

Biotechs often have small teams and each individual plays a significant role. Leadership must maintain investor relationships and build a cohesive team aligned with strategic goals. They also need to decide what work stays in-house and what is outsourced to a CRO to extend the team’s expertise.

What’s the key to building an effective biotech development strategy?

Biotechs must plan early and align all activities with a defined end goal, such as regulatory approval or a key fundraising round. It’s essential to understand potential risks, consider all data requirements and develop a disciplined execution plan.

How are biotech clinical trials support through protocol design?

Biotechs should ensure their protocols are scientifically focused, operationally feasible, patient-centric and supported by appropriate data. It’s important to discuss development plans with regulatory authorities early, especially for advanced therapies, and consult subject matter experts to avoid costly missteps and align with evolving regulations.

How can working with a CRO (Contract Research Organization) enhance biotech solutions?

Biotech CROs bring scientific and regulatory experience, promote operational efficiencies, leverage global site and KOL (Key Opinion Leader) networks and develop strategic approaches in trial design and execution. They support biotech research and development, managing the complexities of drug development while allowing the biotech to focus on their core business and fundraising.

What is the outlook for biotech innovation?

Despite high risks and costs, biotechs are increasingly capable of taking drugs from discovery through commercialization—especially with strong strategic planning and the right support.

fortrea

Displaying 61 - 70 of 634

Thank you for your interest in a Fortrea Intelligent Technology demo

Event

Outsourcing in Clinical Trials West Coast 2026

Wed, 02/11/2026 - 12:00 - Thu, 02/12/2026 - 12:00

Burlingame, CA

Biotech

Event

ISCR Annual Conference 2026

Fri, 02/13/2026 - 12:00 - Sat, 02/14/2026 - 12:00

New Delhi, India

Fortrea Intelligent Technology

Event

JP Morgan Week 2026

Mon, 01/12/2026 - 12:00 - Thu, 01/15/2026 - 12:00

San Francisco, CA

Case Study 18 December 2025

Helping clinical trial sites thrive: Lessons learned from Fortrea’s Site Support and Mobile Clinical Services

Download Case Study

helping-clinical-trial-sites-thrive-site-support-mobile-clinical-services

Blog 17 December 2025

A Year of Progress, A Future of Hope

White Paper 17 December 2025

Patient perspectives on CAR-T therapy clinical trial setting

Download White Paper

Blog 12 December 2025

FDA’s Menopause Policy Shift: What It Means for Sponsors and Innovators

Book a Meeting

Thank you for your interest in a Fortrea Intelligent Technology demo

Outsourcing in Clinical Trials West Coast 2026

Biotech

ISCR Annual Conference 2026

Fortrea Intelligent Technology

JP Morgan Week 2026

Helping clinical trial sites thrive: Lessons learned from Fortrea’s Site Support and Mobile Clinical Services

A Year of Progress, A Future of Hope

Patient perspectives on CAR-T therapy clinical trial setting

FDA’s Menopause Policy Shift: What It Means for Sponsors and Innovators

Choose how you like to connect.

Prefer to send an inquiry?

Need to speak directly with our sales team?